TRCT
GNLX icon

Tower Research Capital (TRC)’s Genelux GNLX Stock Holding History

Tower Research Capital (TRC)’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,885
Closed -$16.9K – 5280
2025
Q4 		$16.9K Buy
3,885
+3,414
+725% +$18.4K ﹤0.01% 3225
2025
Q3 		$1.98K Buy
+471
New +$1.67K ﹤0.01% 4704
2025
Q1 		– Sell
-592
Closed -$1.4K – 5426
2024
Q4 		$1.4K Sell
592
-42
-7% -$112 ﹤0.01% 5028
2024
Q3 		$1.5K Sell
634
-6,663
-91% -$14.7K ﹤0.01% 5146
2024
Q2 		$14.2K Buy
7,297
+5,566
+322% +$18.9K ﹤0.01% 3956
2024
Q1 		$11.1K Sell
1,731
-1,225
-41% -$11.1K ﹤0.01% 3601
2023
Q4 		$41.4K Buy
2,956
+2,021
+216% +$31.9K ﹤0.01% 3251
2023
Q3 		$22.9K Buy
935
+761
+437% +$19.3K ﹤0.01% 3254
2023
Q2 		$5.69K Sell
174
-973
-85% -$27.4K ﹤0.01% 4800
2023
Q1 		$32K Buy
+1,147
New +$18.6K ﹤0.01% 2921

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tower Research Capital (TRC)'s GNLX Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Genelux (GNLX) in Q1 2026, closing a stake of 3,885 shares — an estimated $16.9K sold.

Tower Research Capital (TRC) first reported a position in GNLX in Q1 2023 and held it in 10 quarters. The position peaked at $41.4K in Q4 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,885 Genelux shares in Q1 2026, an estimated $16.9K.
  • Tower Research Capital (TRC) first reported a position in Genelux in Q1 2023 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Genelux position peaked at $41.4K in Q4 2023.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.